NASDAQ Healthcare Biotechnology OCUL

Ocular Therapeutix, Inc.

OCUL

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat

Dividends

Dividend payout ratio
0.00 %
Dividend split
Date Split